These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 20376044)

  • 1. Behind the paper: saved from the drain.
    Dolgin E
    Nat Med; 2010 Apr; 16(4):378. PubMed ID: 20376044
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P
    Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral therapy for multiple sclerosis!].
    de Seze J
    Rev Neurol (Paris); 2010 Apr; 166(4):363-4. PubMed ID: 20385331
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis].
    Seres E; Vécsei L
    Ideggyogy Sz; 2006 May; 59(5-6):156-62. PubMed ID: 16786710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
    Giuliani F; Fu SA; Metz LM; Yong VW
    J Neuroimmunol; 2005 Aug; 165(1-2):83-91. PubMed ID: 15958276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new treatment for multiple sclerosis.
    Piascik P
    Am Pharm; 1993 Dec; NS33(12):25-6. PubMed ID: 8304268
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon beta-1B for multiple sclerosis.
    Med Lett Drugs Ther; 1993 Jul; 35(900):61-2. PubMed ID: 8515719
    [No Abstract]   [Full Text] [Related]  

  • 8. Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis.
    Nadjar Y; Coutelas E; Prouteau P; Panzer F; Paquet D; Saint-Val C; Créange A
    Clin Neurol Neurosurg; 2011 May; 113(4):316-22. PubMed ID: 21269761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High doses of interferon in the treatment of multiple sclerosis].
    Muñoz D
    Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
    [No Abstract]   [Full Text] [Related]  

  • 10. [Has it been indicated already to use beta-interferon in patients with multiple sclerosis?].
    Fernández O
    Rev Neurol; 1995; 23(123):986-90. PubMed ID: 8556611
    [No Abstract]   [Full Text] [Related]  

  • 11. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, comparative study of interferon beta-1a treatment regimens in MS: the EVIDENCE trial.
    Byrne E
    Neurology; 2003 Jun; 60(11):1872; author reply 1872-3. PubMed ID: 12796564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interferon-1 beta in the treatment of multiple sclerosis].
    Nervenarzt; 1995 Sep; 66(9 Suppl Interferon):1-16. PubMed ID: 9131093
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon beta for treatment of multiple sclerosis.
    Wilson BA
    Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
    [No Abstract]   [Full Text] [Related]  

  • 15. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of multiple sclerosis: the PROOF trial.
    Boster A; Racke MK
    Expert Opin Pharmacother; 2009 Jun; 10(8):1235-7. PubMed ID: 19463066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of multiple sclerosis with beta-interferon.
    Poser CM
    Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta 1b: new hope for multiple sclerosis.
    Holdcroft C
    Nurse Pract; 1994 Jan; 19(1):6. PubMed ID: 8139804
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L; Neves M; Cardoso E; Melo A
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.